Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Accurate Sample Assignment in a Multiplexed, Ultrasensitive, High-Throughput Sequencing Assay for Minimal Residual Disease

13 May 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Cancer Genomics and Diagnostics
Share to Single-cell and spatial transcriptomics

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 27183494
DOI: 10.1016/j.jmoldx.2016.02.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Accurate Sample Assignment in a Multiplexed, Ultrasensitive, High-Throughput Sequencing Assay for Minimal Residual DiseasePMID 27183494Read ↗

Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological MalignanciesSemantic proximity Read ↗

Minimal Residual Disease in Oncology: From Cure to Longitudinal Patient ManagementSemantic proximity Read ↗

Next-generation molecular diagnosis: single-cell sequencing from bench to bedsideSemantic proximity Read ↗

In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detectionSemantic proximity Read ↗

MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies.Semantic proximity Read ↗

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.Semantic proximity Read ↗

Optimization and Validation of Multimodular, Long-Range PCR–Based Next-Generation Sequencing Assays for Comprehensive Detection of Mutation in Tuberous Sclerosis ComplexSemantic proximity Read ↗

Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide VariationsSemantic proximity Read ↗

RNA sequencing for research and diagnostics in clinical oncologySemantic proximity Read ↗

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersSemantic proximity Read ↗

Validation of the high-performance of pyrosequencing for clinical <i>MGMT</i> testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialSemantic proximity Read ↗

ACMG clinical laboratory standards for next-generation sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.